UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported 9/2/2005)
Med Gen Inc.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 000-29171 65-0703559
- --------------------------- ---------------- -------------------
(State or other Jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
7284 West Palmetto Park Road, Suite #207, Boca Raton, FL 33433
- -------------------------------------------------------------------------
(Address of principal executive offices)
561-750-1100
- -------------------------------------------------------------------------
(Issuer's telephone number)
Not Applicable
- -------------------------------------------------------------------------
(Former name or former address, if changed since last report)
All Correspondence to:
Paul B Kravitz CEO
C/O Med Gen Inc.
7284 West Palmetto Park Road
Suite #207
Boca Raton, FL 33433
Item 8.01 Other Events.
------------
The Board of Directors and NASDAQ have approved a 20:1 reverse split
of all of the issued outstanding common shares. The effective date of
the split shall be 9-6-2005 for all shareholders of record at the closing
of business 9-2-2005. The old symbol MDGN will be replaced by a new symbol
and the Cusip Number has been changed to : 58401X 30 8
The total outstanding shares as of the date of the 8-K filing is 53,176,447.
After the reverse the total outstanding shares will be 2,658,822. All
fractional shares will be reduced to the lower number by the Transfer Agent
effective 9-6-2005.
The new symbol will be MGEN.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Med Gen Inc.
Date: September 2, 2005
/s/Paul B. Kravitz
----------------------------------
Paul B. Kravitz,
Chairman & Chief Executive Officer